Join
Live feed
·
SECFilingvia Quantisnow
Acurx Pharmaceuticals Inc. logo

Acurx Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
ACXP· Acurx Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACXP (Acurx Pharmaceuticals Inc.) and more on Quantisnow.